2.81 USD
▲+0.13+5.64%
盘后 2.88 +8.27%
2026-08-03
市值
$6.44M
市盈率
—
EPS
-1.18
股息率
—
52 周区间
1.90 – 13.93
成交量
67.95K
Beta
2.20
目标价
—
52W 低 1.9052W 高 13.93
价格走势
公司简介
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company’s product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the tr...